Acero D et al. The kids get their vitamins, I get my meds: Women living with HIV strategising 'compliance' for themselves and their peers. National Conference on Women and HIV, abstract P2.72, 1997.

Adam BD et al. Adherence practices among people living with HIV. AIDS Care 15: 263-274, 2003.

Ahmad WIU et al. 'Race and statistics' in Hammersley, M. (ed) Social Research: Philosophy, Politics and Practice, London; Sage, 1993.

Ammassarri A et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 45(5): 394-402, 2004.

Arabe J et al. Factors which influence adherence to the use of protease inhibitors. Twelfth World Conference on AIDS, Geneva, abstract 32404, 1998.

Anderson W & Weatherburn P. The impact of combination therapy on the lives of people with HIV. London; Sigma Research, 1998.

Anderson W & Weatherburn P. Taking heart? The impact of combination therapy on the lives of people with HIV (phase 2). London; Sigma Research, 1999

Babudiere S et al. Directly observed therapy to treat HIV infection in prisoners. Journal of the American Medical Association 284: 179-180, 2000

Bachiller P et al. Adherence to antiretroviral therapy in HIV-infected patients. Twelfth World Conference on AIDS, Geneva, abstract 32392, 1998.

Bakken S et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care and STDS 14(4): 189-97, 2000.

Balfour V et al. Adherence to HIV protease inhibitor therapy and maximal suppression of plasma viremia: when is adherence enough? AIDS Impact, Fourth International Conference on the Biopsychosocial Aspects of HIV Infection, Ottawa, 1999.

Bangsberg DR et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 15(9): 1181-1183, 2001.

Bangsberg DR et al. A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care 14(1): 3-15, 2002.

Becker MH (ed). The Health Belief Model and Personal Health Behaviour. New Jersey; Charles B. Slack, 1974.

Besch CL. Compliance in clinical trials. AIDS 1995(9): 1-10, 1995.

Bogart LM et al. Association of stereotypes about physicians to health care satisfaction, help-seeking behavior, and adherence to treatment. Social Science Medicine 58(6): 1049-1058, 2004.

Bouhnik AD et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. Journal of Acquired Immune Deficiency Syndromes 31 Suppl 3: S149-153, 2002.

Bowling A. Research methods in health, Buckingham: OUP, 1997.

Broadhead R et al. Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Social Science Medicine 55(2): 235-246, 2002.

Broers B et al. A cohort of drug users' compliance with zidovudine treatment. Archives of Internal Medicine (154): 1121-1127, 1994.

Burgos M et al. Obstacles in treatment adherence: Patient reasons. Twelfth World Conference on AIDS, Geneva, abstract 32400, 1998.

Carrieri P et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. Journal of AIDS 28(3): 232-239, 2001.

Carrieri MP et al. Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. International Journal of Behavioural Medicine 10(1): 1-14, 2003.

Collier AC et al. Randomized study of telephone calls to improve adherence to antiretroviral therapy. Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, abstract 540-T, 2002.

Conrad PC. The meaning of medications: another look at compliance. Social Science and Medicine 20(1): 29-37, 1985.

Cook RL et al. Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine 16(2): 83-88, 2001.

Crespo-Fierro M. Compliance/adherence and care management in HIV disease. Journal of the Association of Nurses in AIDS Care 8(4): 43-54, 1997.

Delgado J et al. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill. Antiviral Therapy 8(5): 471-478, 2003.

Demas P et al. Stress, coping and attitudes towards HIV treatment in injecting drug users: a qualitative study. AIDS Education and Prevention 7(5): 429-442, 1995.

DeMasi RA et al. Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Advances in Therapy 18(4): 163-173, 2001.

Di Iorio C et al. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. Journal of the Association of Nurses in AIDS Care 14(2): 52-62, 2003.

Donovan JL et al. Patient non-compliance: deviance or reasoned decision-making? Social Science and Medicine 34(5): 507-513, 1992.

Dunbar PJ et al. A two-way messaging system to enhance antiretroviral adherence. Journal of American Medical Information Association 10: 11-15, 2003.

Duran S et al. 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study. AIDS 15(8): 1075-1077, 2001.

Duran S et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS 15(18): 2441-2444, 2001b.

Durante AJ et al. Home-based study of anti-HIV drug regimen adherence among HIV-infected women: feasibility and preliminary results. AIDS Care 15(1): 103-115, 2003.

Eldred LJ et al. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 18(2): 117-125, 1998.

Eraker SA et al. Understanding and improving patient compliance. Annals of Internal Medicine (100): 258-268, 1984.

Fairley CK et al. Randomized trial of an adherence programme for clients with HIV. International Journal on STDs and AIDS 14(12): 805-809, 2003.

Farley J et al. Assessment of adherence to antiviral therapy in HIV-infected children using the medication event monitoring system, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. Journal of Acquired Immune Deficiency Syndromes 33(2): 211-218, 2003.

Ferrando SJ et al. Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease. American Journal of Drug and Alcohol Abuse 22(4): 475-487, 1996.

Fischl M et al. Impact of directly observed therapy on outcomes in HIV clinical trials. Seventh Conference on Retroviruses and Opportunistic Infections, San Francisco, abstract 71, 2000.

Flandre P et al. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial. Antiviral Therapy 7(2): 113-121, 2002.

Fourney AM et al. Formative evaluation of an intervention to increase compliance to HIV therapies: the ALP project. Health Promotion Practice 4(2): 165-170, 2003.

Freeman RC et al. Compliance with AZT treatment regimen of HIV-seropositive injection drug users: a neglected issu. AIDS Education and Prevention 8(1): 58-71, 1996.

Fumaz CR et al. Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens. Journal of Acquired Immune Deficiency Syndromes 29(3): 244-253, 2002.

Gao X et al. The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care 12(4): 387-398, 2000.

Gebo KA et al. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. Journal of General Internal Medicine 18(2): 104-111, 2003.

Gifford AL et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes 23(5): 386-395, 2000.

Gifford AL et al. Effects of group HIV patient education on adherence to antiretrovirals: a randomized controlled trial. Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, abstract 479, 2001.

Goldie SJ et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. American Journal of Medicine 115(8): 632-641, 2003.

Golin C et al. Secret pills: HIV-positive patients' experiences taking antiretroviral therapy in North Carolina. AIDS Education and Prevention 14(4): 318-329, 2002.

Golin CE et al. A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine 17(10): 756-765, 2002.

Golin CE et al. Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in North Carolina. Journal of General Internal Medicine 19(1): 16-27, 2004.

Good M et al. Adherence issues in children and adolescents receiving highly active antiretroviral therapy. AIDS Care 15(3): 403-408, 2003.

Goujard C et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes 34(2): 191-194, 2003.

Graham K et al. Interventions and patient outcome from a pharmacist-based HIV medication adherence referral clinic, Twelfth World Conference on AIDS, Geneva, abstract 390/32323, 1998.

Gross R et al. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 15(16): 2109-2117, 2001.

Hales G et al. Validity of patient questioning versus pill count as an assessment of compliance. Twelfth World Conference on AIDS, Geneva, abstract 32373, 1998.

Halkitis P et al. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care 15(1): 89-102, 2003.

Haubrich RH et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 13: 1099-1107, 1999.

Hecht FM et al. Measuring HIV treatment adherence in clinical practice. AIDS Clinical Care 19(8): 57-59, 1998.

Heckman BD et al. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Care 16(2): 219-230, 2004.

Hedge B. Take as prescribed: a study of adherence behaviours in people taking anti-retroviral medications. Twelfth World Conference on AIDS, Geneva, abstract 32348, 1998.

Heinasmaki et al. Adherence and antiretroviral responses to highly active antiretroviral therapy (HAART) in patients infected with human immunodeficiency virus (HIV): comparison between an outpatient unit and a clinical trials unit. Twelfth World Conference on AIDS, Geneva, abstract 3238, 1998.

Holzemer WL et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care and STDS 13(3): 185-197, 1999.

Holzemer WL et al. The Client Adherence Profiling-Intervention Tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study. Journal of the Association of Nurses in AIDS Care. 11(1): 36-44, 2000.

Horne R et al. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. International Journal of STDs and AIDS 15(1): 38-44, 2004.

Howard AA et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 16(16): 2175-2182, 2002.

Hugen PW et al. Assessment of adherence to protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse support, and therapeutic drug monitoring. Journal of Acquired Immune Deficiency Syndromes 30(3): 324-34, 2002.

Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 16(2): 199-211, 2004.

Johnson MO et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care and STDs 17(12) :645-656, 2003.

Johnstone BE et al. Adherence to highly active antiretroviral therapy among HIV-infected patients of the inner city. Twelfth World Conference on AIDS, Geneva, abstract 32389, 1998.

Johnston Roberts K et al. Adherence to antiretroviral medications in hiv/aids care: a narrative exploration of one woman's foray into intentional nonadherence. Health Care Women International 24(6): 552-564, 2003.

Jones AM et al. A qualitative study on retroviral therapy: drug compliance in IVDU patients. Twelfth World Conference on AIDS, Geneva, abstract 32361, 1998.

Jones DL et al. Influencing medication adherence among women with AIDS. AIDS Care 15(4): 463-474, 2003.

Kaplan AH et al. Adherence to protease inhibitor therapy and viral load. Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, abstract no.96, 1999.

Katko E et al. Assessment of adherence with medications in human immunodeficiency virus-infected children. Pediatric Infectious Diseases Journal 20(12): 1174-1176, 2001.

Kirkland LR et al. Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment. Clinical Infectious Diseases 34(4): 511-518, 2002.

Kitahata MM et al. Electronic human immunodeficiency virus (HIV) clinical reminder system improves adherence to practice guidelines among the University of Washington HIV Study Cohort. Clinical Infectious Diseases 36(6): 803-811, 2003.

Klosinski LE et al. Predictors of non-adherence to HIV combination therapies, Twelfth World Conference on AIDS, Geneva, abstract 32375, 1998.

Knobel H et al. Adherence to very active antiretroviral treatment: impact of individualized assessment. Enfermedades Infecciosas y Microbiologia Clinica 17(2): 78-81, 1999.

Kunches L et al. Educational and support needs of people living with HIV (PLWH) to improve adherence to highly active antiretroviral therapy (HAART). Twelfth World Conference on AIDS, Geneva, abstract 32333, 1998.

Laine C et al. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstetrics and Gynecology 95(2): 167-173, 2000.

Levy R L et al. Social support and compliance: A selective review and critique of treatment integrity and outcome measurement. Social Science and Medicine 17(18): 1329-1338.

Linsk NL et al. Of magic bullets and social justice: Emerging challenges of recent advances in AIDS treatment. Health and Social Work 22(1): 70-74, 1997.

Liu H et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine 134(10): 968-977, 2001.

Liu H et al. Repeated measured longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity and other factors. J Acquir Immune Defic Syndr 41: 315-322, 2006.

Lorenzen T et al. Compliance with antiretroviral multidrug therapy in HIV-infected patients and reasons for non-compliance. Twelfth World Conference on AIDS, Geneva, abstract 32371, 1998.

Lucas GM et al. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 16(5): 767-774, 2002.

Lyon ME et al. A Family Group Approach to Increasing Adherence to Therapy in HIV-Infected Youths: Results of a Pilot Project. AIDS Patient Care STDS 17(6): 299-308, 2003.

Malcom SE et al. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care 15(2): 251-261, 2003.

Mannheimer S et al. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases 34(8): 1115-21, 2002.

Martini M et al. Perceptions of disease and therapy are factors influencing adherence to antiretroviral therapy. Sexually Transmitted Infections 76(6): 496-497, 2000.

McCance-Katz EF et al. Modified directly observed therapy (MDOT) for injection drug users with HIV disease. American Journal of Addiction 11(4): 271-278, 2002.

Miller LG et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med 17: 1-11, 2002.

Miller LG et al. Patient preferences regarding antiretroviral therapy. Int J STDs AIDS 13: 593-601, 2002.

Miller LG et al. Impact of antiretroviral regimen switches on adherence. HIV Clin Trials 3: 355-360, 2002c.

Miller LG et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis 36: 514-518, 2003.

Mitty JA et al. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clin Infect Dis 34: 984-990, 2002.

Molassiotis A et al. A pilot study of the effects of a behavioural intervention on treatment adherence in HIV-infected patients. AIDS Care 15: 125-135, 2003.

Morse EV et al. Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science and Medicine 32(10): 1161-1167, 1994.

Mostashari F et al. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirololgy 18(4): 341-348, 1998.

Muma RD et al. Zidovudine adherence among individuals with HIV infection. AIDS Care 7(4): 439-47, 1995.

Munzenberger N et al. Observance during clinical trials in HIV infection. A discontinuity between patient history and trial logic. Presse Medicale 26(8): 358-365, 1997.

Murphy DA et al. Factors associated with antiretroviral adherence among HIV-infected women with children. Women's Health 36(1): 97-111, 2002.

Murphy DA et al. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 15(2): 217-230, 2003.

Nakashima AK et al. Adherence to currently prescribed antiretroviral therapies: results from a multisite interview project. Twelfth World Conference on AIDS, Geneva, abstract 392/32326, 1998.

Ohmit S et al. Adherence to antiretroviral therapy (ART) among women in the HIV Epidemiology Research Study (HERS) and Women's Inter-Agency HIV Study (WIHS). Twelfth World Conference on AIDS, Geneva, abstract 32347, 1998.

Paiva V. Compliance with reverse transcriptase inhibitors and combination therapy among HIV+ women in Sao Paulo, Brazil. Twelfth World Conference on AIDS, Geneva, abstract 32399, 1998.

Palepu A et al. Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. Journal of Acquired Immune Deficiency Syndromes 15;32(5): 522-526, 2003.

Palmer NB et al. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care and STDs 17(12): 635-644, 2003.

Paterson et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 133(1): 21-30, 2000.

Pattullo ALS et al. Heterogeneity of care for HIV-infected individuals decreases with the physician knowledge. International Journal of STD and AIDS 7(6): 435-438, 1998.

Porter AMW et al. Drug defaulting in general practice. British Medical Journal 1: 218-222, 1969.

Powell-Cope GM et al. Perceived health care providers support and HIV adherence. Twelfth World Conference on AIDS, Geneva, abstract 32354, 1998.

Powell-Cope GM et al. Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care 15(2): 239-249, 2003.

Power R et al. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care and STDs 17(5): 245-252, 2003.

Pradier C et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clinical Trials 4(2): 121-131, 2003.

Pratt RJ et al. Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical practice. HIV Clinical Trials 2(2): 146-159, 2001.

Rawlings MK et al. Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 34(2): 174-183, 2003.

Rigsby MO et al. Cue-dose training with monetary reinforcement: a pilot study of an antiretroviral adherence intervention. Journal of General Internal Medicine 15(12): 841-847, 2000.

Rimer BK et al. Perspectives on intrapersonal theories in health education and health behavior, in: Glanz, K. Marcus-Lewis, F. & Rimer, BK. (Eds) Health Behavior and Health Education, San Francisco; Jossey-Bass Publishers, 140-158.

Rodriguez-Rosado R et al. Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS 12(9): 1112-1113, 1998.

Rosenstock IM. Why people use health services. Milbank Quarterly 1966(44): 94-127, 1966.

Rubin DS. Success of HAART in an urban, working-class setting. Infectious Diseases Society of American 35th Annual Meeting, Moscone Centre, San Francisco, 1997.

Safren SA et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behavioural Research Therapy 39(10): 1151-1162, 2001.

Safren SA et al. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 15(6): 787-793, 2003

Samet JH. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus type I: a cross-sectional study in a municipal hospital clinic. American Journal of Medicine 92: 495-502, 1992.

Samet JH et al. A randomised controlled trial of a multidimensional intervention to enhance adherence to antiretroviral therapy in HIV-infected patients with a history of alcohol problems. Fourteenth International AIDS Conference, Barcelona, abstract MoPeB3286, 2002.

Sethi AK et al. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 37 (8):1112-1118, 2003.

Siegel K et al. HIV-infected women: barriers to AZT use. Social Science and Medicine 45(1): 15-22, 1997.

Simoni JM et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Topics in HIV Medicine 11(6): 185-198, 2003.

Singh N et al. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 8(3): 261-269, 1996.

Smith MY et al. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy. Journal of General Internal Medicine 12(4): 216-223, 1996.

Smith SR et al. A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counselling 50(2): 187-199, 2003.

Sorensen JL et al. Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care 10: 297-312, 1998.

Spire B et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Social Science Medicine 54(10): 1481-1496, 2002.

Stenzel MS et al. Enhancing adherence to HAART: a pilot program of modified directly observed therapy. AIDS Reader 11(6): 317-319, 2001.

Stone VE et al. HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. Journal General Internal Medicine 13(9): 586-593, 1998.

Stone VE et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. Journal of Acquired Immune Deficiency Syndromes 28(2): 124-131, 2001.

Stone VE et al. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clinical Infectious Diseases 33(6): 865-872, 2001b.

Stone VE et al. Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. Clinical Infectious Diseases 34(7): 984-990, 2002.

Tebas P et al. Relationship between adherence to HAART and disease state. Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, abstract no.149, 1998.

Tesoriero J et al. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the Treatment Adherence Demonstration Project. Journal of Acquired Immune Deficiency Syndromes 33: 484- 492, 2003.

Tucker JS et al. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine 114(7): 573-580, 2003.

Tuldra A et al. Visual Analogue Scale (VAS) to assess the difficulty of highly active antiretroviral treatments (HAART) adherence. Twelfth World Conference on AIDS, Geneva, abstract 60535, 1998.

Tuldra A et al. Monitoring adherence ot HIV therapy. Archives of Internal Medicine 159:1376-1377, 1999.

Tuldra A et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 25(3): 221-228, 2000.

Ungvarski P. Adherence to prescribed HIV-1 protease inhibitors in the home setting. Journal of the Association of Nurses in AIDS Care, 8 Suppl: 37-45, 1997.

van Rossum AM et al. Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children. Pediatric Infectious Diseases Journal 21(8): 743-747, 2002.

van Servellen G et al. Program to enhance health literacy and treatment adherence in low-income HIV-infected Latino men and women. AIDS Patient Care and STDs17(11): 581-594, 2003.

Vilas A et al. Bearing of professional practices on patient adherence to antiretroviral treatments. Twelfth World Conference on AIDS, Geneva, abstract 42438, 1998.

Wagner GJ et al. Placebo practice trials: a tool to assess and improve adherence readiness. HIV Clinical Trials 3(6): 475-481, 2002.

Wagner GJ et al. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care and STDs 17(4): 179-186, 2003.

Walker B et al. AIDS and the doctor-patient relationship. Social Studies Review 6(4): 128-130, 1991.

Walsh J et al. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 16: 269-277, 2002.

Walsh J et al. Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance. Journal of Acquired Immune Deficiency Syndromes 30(3): 278-287, 2002b.

Weidle PJ et al. Adherence to antiretroviral medications in an inner-city population. Journal of Acquired Immune Deficiency Syndromes 22(5): 498-502, 1999.

Weiss JJ et al. Attitudes and age are related to adherence to combination therapy in HIV-1 positive gay men. Twelfth World Conference on AIDS, Geneva, abstract 32331, 1998.

Williams A et al. Adherence, compliance and HAART. AIDS Clin Care 9: 51-54, 1997.

Williams M et al. Perceived compliance with AZT dosing among a sample of African-American drug users. Int J STDs AIDS 11: 57-63, 2000.

Wood B et al. Ensuring adherence: A patient-team model. Twelfth World Conference on AIDS, Geneva, abstract 24286, 1998.

Wood E et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med 139: 810-816, 2003.

Wood E et al. Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy. J Infect Dis 188: 1421-1425, 2003b.

Workman C et al. The process of supporting adherence. Focus 14: 1-4, 1999.